In the phase 3 B-Well trials, about 1 in 5 adults reached functional cure after a fixed course, but a boxed warning makes monitoring key for pharmacists.
|Videos|July 24, 2013
Effective Utilization Management Programs for Specialty Pharmacies
Specialty pharmacies can minimize "cost to treat" by identifying which specialty drugs have dose optimization opportunities, noted Michael Einodshofer, RPh, MBA, director of utilization management, Walgreens, at the 2013 PBMI Drug Benefit Conference.
Advertisement
Specialty pharmacies can minimize "cost to treat" by identifying which specialty drugs have dose optimization opportunities, noted Michael Einodshofer, RPh, MBA, director of utilization management, Walgreens, at the 2013 PBMI Drug Benefit Conference.
For more videos featuring Michael Einodshofer, click on our
Advertisement
Related to this article
Parminder K. Judge, PhD, explains why eGFR and electrolytes should be monitored when diuretics are added to reach intensive BP targets in patients with CKD
The once-daily device, bioequivalent to the existing prefilled syringe, gives adults with AChR antibody-positive generalized MG a second self-injection option.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
2
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
3
Recap: Tirzepatide Is Approved to Cut Cardiovascular Risk in Type 2 Diabetes
4
Oncology Pharmacists Reduce Adverse Drug Reactions in Hematologic Cancer Care
5